AU2001233687A1 - Instant granules and process for their formulation - Google Patents

Instant granules and process for their formulation

Info

Publication number
AU2001233687A1
AU2001233687A1 AU2001233687A AU3368701A AU2001233687A1 AU 2001233687 A1 AU2001233687 A1 AU 2001233687A1 AU 2001233687 A AU2001233687 A AU 2001233687A AU 3368701 A AU3368701 A AU 3368701A AU 2001233687 A1 AU2001233687 A1 AU 2001233687A1
Authority
AU
Australia
Prior art keywords
active substance
coated
soluble
carrier material
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233687A
Inventor
Gerhard Gergely
Irmgard Gergely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Gergely and Co
Original Assignee
Dr Gergely and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Gergely and Co filed Critical Dr Gergely and Co
Publication of AU2001233687A1 publication Critical patent/AU2001233687A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A pharmaceutical instant granulate based on carrier material granules coated with active substances has either sugar alcohols and soluble hydrocolloids as the carrier materials and is coated with active substance in a specific weight ratio and/or has one carrier material coated with a specific percentage of active substance and a second carrier material coated with remaining active substance and granulated. A pharmaceutical instant granulate comprises granules of at least two soluble carrier materials coated with at least one layer of a (preferably insoluble or difficultly soluble) active substance and has: A) at least one sugar alcohol, especially mannitol or sorbitol, and at least one soluble hydrocolloid, especially maltodextrin, as the carrier materials and 50-120 parts by weight, preferably 60-100 parts by weight, of active substance per part by weight carrier materials; and/or B) 50-80 wt.% of a first carrier material coated with a layer containing only part of the active substance and a second more soluble carrier material coated with the remaining active substance and granulated. An Independent claim is also included for the preparation of the granulate.
AU2001233687A 2000-01-10 2001-01-08 Instant granules and process for their formulation Abandoned AU2001233687A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH332000 2000-01-10
CH0033/00 2000-01-10
EP00101924 2000-02-01
EP00101924A EP1116485A3 (en) 2000-01-10 2000-02-01 Instant granulate and process for its preparation
PCT/EP2001/000096 WO2001051026A2 (en) 2000-01-10 2001-01-08 Instant granules and process for their formulation

Publications (1)

Publication Number Publication Date
AU2001233687A1 true AU2001233687A1 (en) 2001-07-24

Family

ID=4253424

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233687A Abandoned AU2001233687A1 (en) 2000-01-10 2001-01-08 Instant granules and process for their formulation

Country Status (13)

Country Link
US (1) US6645529B2 (en)
EP (2) EP1116485A3 (en)
JP (1) JP4959895B2 (en)
CN (1) CN1179720C (en)
AT (1) ATE292958T1 (en)
AU (1) AU2001233687A1 (en)
CA (1) CA2396223C (en)
DE (1) DE60110034T2 (en)
DK (1) DK1246610T3 (en)
ES (1) ES2240405T3 (en)
NO (1) NO328899B1 (en)
RU (1) RU2262336C2 (en)
WO (1) WO2001051026A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
PT1031346E (en) 1999-01-27 2002-09-30 Idea Ag NOT INVASIVE VACCINATION THROUGH SKIN
DK1031347T3 (en) 1999-01-27 2002-07-08 Idea Ag Transnasal transport / immunization with highly customizable carriers
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
JP3211824B1 (en) * 2000-10-26 2001-09-25 味の素株式会社 Pharmaceutical granule preparation containing branched-chain amino acid and method for producing the same
JP4221299B2 (en) * 2001-12-21 2009-02-12 ビーオパルトナーズ ゲーエムベーハー Ribavirin granules for film tablet production
JP3368898B1 (en) * 2002-01-24 2003-01-20 味の素株式会社 Process for producing granules containing branched chain amino acids
WO2004017947A1 (en) * 2002-08-21 2004-03-04 Phoqus Pharmaceuticals Limited Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
US9247765B2 (en) 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
US20080095722A1 (en) * 2004-11-12 2008-04-24 Idea Ag Extended Surface Aggregates in the Treatment of Skin Conditions
UA95093C2 (en) 2005-12-07 2011-07-11 Нікомед Фарма Ас Method for the preparation of calcium-containing compound
US9974319B2 (en) 2006-03-29 2018-05-22 Purac Biochem B.V. Partially neutralized polycarboxylic acids for acid-sanding
TWI503128B (en) 2007-07-31 2015-10-11 Ajinomoto Kk A granule preparation containing an amino acid with excellent taste
WO2011043647A1 (en) 2009-10-09 2011-04-14 N.V. Nutricia Amino acid composition with improved dispersibility
KR101125453B1 (en) * 2010-07-29 2012-03-27 주식회사 대웅제약 Solubilizing Compositions of L-Tryptophan and Pharmaceutical preparation therefrom
CN105076729A (en) * 2015-09-16 2015-11-25 中粮饲料有限公司 Feed additive microcapsule and preparation method thereof
CN106806345B (en) * 2015-11-27 2020-10-13 北京科信必成医药科技发展有限公司 Ribavirin taste masking granules and preparation method thereof
CN113974171A (en) * 2021-11-08 2022-01-28 北京素维生物科技有限公司 Slightly water-soluble composition, slightly water-soluble food or medicine and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
DE2618100A1 (en) * 1976-04-26 1977-11-03 Fresenius Chem Pharm Ind TASTE-NEUTRAL GRANULES CONTAINING L-AMINO ACIDS
IT1212792B (en) * 1983-11-30 1989-11-30 Egidio Aldo Moja DIETARY SUPPLEMENT AND PRE-PACKED FOOD THAT CONTAINS IT PREPARATION PROCEDURE AND METHOD OF ADMINISTRATION
DE3440288C2 (en) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmaceutical preparation containing ibuprofen and process for its preparation
JPH07106977B2 (en) * 1984-12-14 1995-11-15 ゲルゲリイ、ゲルハルト Method for making particles of hydrophobic or sparingly soluble substance hydrophilic
FR2682874B1 (en) * 1991-10-24 1993-12-10 Rinrone Ets PROCESS FOR THE PREPARATION OF AN EXTRACT OF ACTIVE PRINCIPLES IN THE DRY ADSORBABLE FORM AND ADSORBABLE MICROGRANULES THUS OBTAINED.
US5455049A (en) * 1995-01-04 1995-10-03 Ascent Pharmaceuticals, Inc. Terfenadine oral powder
DE19733505A1 (en) * 1997-08-01 1999-02-04 Knoll Ag Fast acting analgesic
US6096343A (en) * 1997-10-27 2000-08-01 Gerhard Gergely Instant calcium/soybean granules, their use and process for their preparation

Also Published As

Publication number Publication date
EP1116485A2 (en) 2001-07-18
RU2002121486A (en) 2004-03-20
ATE292958T1 (en) 2005-04-15
CN1394136A (en) 2003-01-29
EP1116485A3 (en) 2002-01-16
US6645529B2 (en) 2003-11-11
CN1179720C (en) 2004-12-15
ES2240405T3 (en) 2005-10-16
JP2003519649A (en) 2003-06-24
EP1246610A2 (en) 2002-10-09
DE60110034T2 (en) 2006-03-02
CA2396223A1 (en) 2001-07-19
DE60110034D1 (en) 2005-05-19
EP1246610B1 (en) 2005-04-13
RU2262336C2 (en) 2005-10-20
NO328899B1 (en) 2010-06-07
JP4959895B2 (en) 2012-06-27
CA2396223C (en) 2009-06-02
NO20022875L (en) 2002-08-06
US20020168386A1 (en) 2002-11-14
WO2001051026A3 (en) 2002-03-21
NO20022875D0 (en) 2002-06-17
DK1246610T3 (en) 2005-08-15
WO2001051026A2 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
AU2001233687A1 (en) Instant granules and process for their formulation
EP0159604B1 (en) Sustained-release preparation applicable to mucous membrane in oral cavity
NZ515230A (en) Fast-dispersing dosage forms containing fish gelatin
KR100358211B1 (en) Granule products or tablets containing foaming systems and pharmaceutical active substances and methods for making them
FI90013B (en) FOUNDATION REQUIREMENTS FRUCTURE BASERAT BINDE- OCH UTSPAEDNINGSMEDEL OCH FOERFARANDE FOER FRAMSTAELLNING AV DETTA
IE901256L (en) Pesticides
AU662128B2 (en) New bi- and tricyclic aminoalcohol esters, their preparation and their use in medicaments
HU195617B (en) Process for producing pharmaceutical compositions containing 2-/4-isobutyl-phenyl6-propionic acid
HUP0004924A2 (en) Pharmaceutical compositions comprising cyclodextrins
AU5122790A (en) A drug-release controlling coating material for long acting formulations
WO2006000229A3 (en) Porous tablets as carriers for liquid formulations
WO2001013891A3 (en) Modulation of release from dry powder formulations
CA2140546A1 (en) Patch for low-melting and/or volatile active substances
WO2003035051A3 (en) The use of proton sequestering agents in drug formulations
AU679200B2 (en) Effervescent pharmaceutical composition containing ibuprofenand method for preparing same
CA2317016A1 (en) Disposable absorbent articles comprising microporous polymer films with registered graphics
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
WO2000051567A8 (en) Processes for making pharmaceutical oral ecb formulations and compositions
PT1195160E (en) Sustained release trimetazidine pharmaceutical compositions and a method of their preparation
DK1171101T3 (en) Process for preparing a water-insoluble amorphous depot matrix
AU5523599A (en) Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
CA2183952A1 (en) Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation
ATE350021T1 (en) PHARMACEUTICAL FORMULATION CONTAINING CARRIER BEADS WITH A LAYER OF VALACICLOVIR APPLIED
WO2000057873A3 (en) Granulate with high content of l-carnitine or an alkanoyl l-carnitine
AU5755898A (en) Formulation in the form of a matrix material-excipient compound, matrix material-active substance compound and/or matrix material-excipient-active substance compound, and processes for the preparation thereof and the use thereof for the preparation of tablets and/or other larger matrix units